Evidence map›Paper›PMID 20431070›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2010

Targeted Vezf1-null mutation impairs vascular structure formation during embryonic stem cell differentiation.

Zhongmin Zou, Pauline A Ocaya, Huiqin Sun, Frank Kuhnert, Heidi Stuhlmann

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Frontiers in medicine · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhongmin ZouDepartment of Cell Biology, Scripps Research Institute, La Jolla, CA, USA.
Pauline A Ocaya
Huiqin Sun
Frank Kuhnert
Heidi Stuhlmann
Scripps Research Institute · US

Funding

Molecular Regulation of Vascular DevelopmentR01HL068648 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI STUHLMANN, HEIDI · 2003 to 2006
$1.7M
FUNCTIONAL ANALYSIS OF VEFZ1, A NOVEL ENDOTHELIAL MARKERR01HL065738 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI STUHLMANN, HEIDI · 2000 to 2003
$1.4M
NHLBI NIH HHS R01 HL065738NHLBI NIH HHS R01 HL068648NHLBI NIH HHS R01-HL65738NHLBI NIH HHS R01-HL68648
6 · The paper itself

Abstract

objectiveVezf1 encodes an early zinc finger transcription factor that is essential for normal vascular development and functions in a dose-dependent manner. Here, we investigated the role of Vezf1 during processes of endothelial cell differentiation and maturation by studying mutant Vezf1 embryonic stem (ES) cells using the in vitro embryoid body differentiation model and the in vivo teratocarcinoma model. METHODS AND

resultsVezf1-/- ES cell-derived embryoid bodies failed to form a well-organized vascular network and showed dramatic vascular sprouting defects. Our results indicate that the retinol pathway is an important mediator of Vezf1 function and that loss of Vezf1 results in reduced retinol/vitamin A signaling and aberrant extracellular matrix (ECM) formation. Unexpectedly, we also uncovered defects during in vitro differentiation of Vezf1-/- ES cells along hematopoietic cell lineages. Vezf1-/- ES cell-derived teratocarcinomas were able to spontaneously differentiate into cell types of all 3 germ layers. However, histological and immunohistochemical examination of these tumors showed decreased cell proliferation, delayed differentiation, and large foci of cells with extensive deposition of ECM. Embryoid bodies and teratocarcinomas derived from heterozygous ES cells displayed an intermediate phenotype.

conclusionsTogether, these results suggest that Vezf1 is involved in early differentiation processes of the vasculature by regulating cell differentiation, proliferation, and ECM distribution and deposition.

Indexed as

Gene Expression Regulation, DevelopmentalMutationAnimalsCell AdhesionCell DifferentiationCell ProliferationCells, CulturedDNA-Binding ProteinsEmbryonal Carcinoma Stem CellsEmbryonic Stem CellsEndothelial CellsExtracellular MatrixGenotypeHematopoietic Stem CellsKruppel-Like Transcription FactorsMaleDNA-Binding ProteinsKruppel-Like Transcription FactorsTranscription FactorsVezf1 protein, mouseVitamin A

Identifiers

PMID20431070
PMCPMC2903440
OpenAlexW2130582031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.